1. Cardiac metabolic imaging: current imaging modalities and future perspectives
- Author
-
Elisabeth H.M. Paiman, Hildo J. Lamb, and Tineke van de Weijer
- Subjects
IN-VIVO ASSESSMENT ,Magnetic Resonance Spectroscopy ,positron emission tomography ,cardiac ,Physiology ,TYPE-2 DIABETES-MELLITUS ,030204 cardiovascular system & hematology ,030218 nuclear medicine & medical imaging ,Phosphocreatine ,Imaging modalities ,H-1 MR SPECTROSCOPY ,ISOLATED RAT-HEART ,Coronary artery disease ,03 medical and health sciences ,chemistry.chemical_compound ,POSITRON-EMISSION-TOMOGRAPHY ,IMPAIRED GLUCOSE-TOLERANCE ,0302 clinical medicine ,Physiology (medical) ,medicine ,Humans ,MYOCARDIAL FATTY-ACID ,CONGESTIVE-HEART-FAILURE ,medicine.diagnostic_test ,business.industry ,Myocardium ,Fatty Acids ,imaging ,MAGNETIC-RESONANCE-SPECTROSCOPY ,medicine.disease ,Functional imaging ,Cardiac Imaging Techniques ,Glucose ,chemistry ,Positron emission tomography ,CORONARY-ARTERY-DISEASE ,Nuclear medicine ,business ,metabolism ,Perfusion ,Emission computed tomography ,Preclinical imaging ,MRI - Abstract
In this review, current imaging techniques and their future perspectives in the field of cardiac metabolic imaging in humans are discussed. This includes a range of noninvasive imaging techniques, allowing a detailed investigation of cardiac metabolism in health and disease. The main imaging modalities discussed are magnetic resonance spectroscopy techniques for determination of metabolite content (triglycerides, glucose, ATP, phosphocreatine, and so on), MRI for myocardial perfusion, and single-photon emission computed tomography and positron emission tomography for quantitation of perfusion and substrate uptake.
- Published
- 2018
- Full Text
- View/download PDF